Results 31 to 40 of about 19,830 (241)

Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers

Cancers, 2023
Simple Summary Disease outcome of patients with pseudomyxoma peritonei (PMP) and appendiceal neoplasms improved gradually in the past decades, as their pathology is better understood, together with a refined subtypisation.
S. Blaj, D. Dora, Z. Lohinai, Z. Herold, A. Szász, J. Herzberg, R. Kodacsi, S. Baransi, H. Schlitt, M. Hornung, Jens M. Werner, Przemyslaw K. Slowik, Miklos Acs, P. Piso   +13 more
semanticscholar   +1 more source

The Cancer Diaspora: A Rare Case of Pseudomyxoma Peritonei of Appendiceal Origin

Journal of Investigative Medicine High Impact Case Reports, 2023
Pseudomyxoma peritonei (PMP) is a rare clinical entity characterized by widespread mucinous implants in the peritoneal cavity. Commonly seen in females in their 50s, PMP typically originates from ruptured appendiceal mucoceles that find refuge in the ...
Lefika Bathobakae MD, MPH, Sacide S. Ozgur MD, Mohita Jariwala BA, Jaydev Kesrani MD, Shajla Ajas MD, Mehandar Kumar MD, Amer Akmal MD   +6 more
doaj   +1 more source

Diagnostic and Therapeutic Algorithm for Appendiceal Tumors and Pseudomyxoma Peritonei: A Consensus of the Peritoneal Malignancies Oncoteam of the Italian Society of Surgical Oncology (SICO)

Cancers, 2023
Simple Summary Pseudomyxoma peritonei (PMP) is an uncommon pathology, and its rarity causes a lack of scientific evidence, precluding the design of a prospective trial.
M. Vaira, M. Robella, M. Guaglio, P. Berchialla, A. Sommariva, M. Valle, E. Pasqual, F. Roviello, M. Framarini, G. Fiorentini, P. Sammartino, Alba Ilari Civit, A. di Giorgio, L. Ansaloni, M. Deraco   +14 more
semanticscholar   +1 more source

The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.

JAMA Surgery, 2021
Importance Studies on the prognostic role of hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei (PMP) are currently not available.
S. Kusamura, F. Barretta, Y. Yonemura, P. Sugarbaker, B. Moran, E. Levine, D. Goéré, D. Baratti, E. Nizri, D. Morris, O. Glehen, A. Sardi, P. Barrios, F. Quénet, L. Villeneuve, A. Gómez-Portilla, I. D. de Hingh, W. Ceelen, J. Pelz, P. Piso, S. González-Moreno, K. van der Speeten, M. Deraco   +22 more
semanticscholar   +1 more source

Serum and ascites tumor markers in the diagnostic and prognostic prediction for appendiceal pseudomyxoma peritonei

BMC Cancer, 2023
Background To investigate the expression of carcinoembryonic antigen (CEA), cancer antigen 199 (CA199) and CA125 in serum and ascites of appendiceal pseudomyxoma peritonei (PMP) patients relative to their diagnostic and predictive value.
Bing Wang, R. Ma, B. Rao, Hongbin Xu
semanticscholar   +1 more source

Under the Hood: Understanding the Features of Mucin in Pseudomyxoma Peritonei

Journal of Clinical Medicine, 2023
Pseudomyxoma peritonei (PMP) is a rare malignant growth characterized by the production of mucin and the potential for peritoneal relapse. This study aimed to investigate the immunohistochemical and biological characteristics of mucin in patients with ...
P. Villarejo-Campos, M. García-Arranz, Siyuan Qian, S. Jiménez de los Galanes, V. Domínguez-Prieto, J. F. Vélez-Pinto, Ismael Guijo Castellano, Montiel Jiménez-Fuertes, H. Guadalajara, D. García-Olmo   +9 more
semanticscholar   +1 more source

Four cases of pseudomyxoma peritonei with ovarian tumors at our hospital

Fukushima Journal of Medical Science, 2023
We describe four cases of pseudomyxoma peritonei (PMP) that were diagnosed and treated at our hospital. Case 1: A 26-year-old woman with a large multicystic ovarian tumor and massive ascites was diagnosed with PMP originating from a borderline mucinous ...
Riho Yazawa, H. Yazawa, K. Fukuda, Miki Ohara, F. Osuka   +4 more
semanticscholar   +1 more source

Long-Term Treatment of Unresectable Pseudomyxoma Peritonei with Multiple Treatments of Intratumoural Bromelain and Acetylcysteine (BromAc®): A Case Report

Case Reports in Oncology, 2023
Pseudomyxoma peritonei is a rare peritoneal malignancy characterized by the progressive accumulation of mucinous material and tumour within the abdomen and pelvis.
Jessica Yang, D. Glenn, S. Lodh, Sarah Valle, D. Morris   +4 more
semanticscholar   +1 more source

Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines

Orphanet Journal of Rare Diseases, 2021
Background Pseudomyxoma peritonei (PMP) is a clinical malignant syndrome mainly originating from the appendix, with an incidence of 2–4 per million people. As a rare disease, an early and accurate diagnosis of PMP is difficult. It was not until the 1980s
Yulin Lin, Dachong Xu, Xin-Bao Li, Fengcai Yan, Hong-Bin Xu, Zheng Peng, Yan Li   +6 more
semanticscholar   +1 more source

Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei. [PDF]

Clin Cancer Res
Purpose: Pseudomyxoma peritonei (PMP) is a rare and poorly understood malignant condition characterized by the accumulation of intra-abdominal mucin produced from peritoneal metastases.
Martínez-Quintanilla J, Cabot D, Sabia D, Arqués O, PMPnet Group, Vergés J, Chicote I, Bijelic L, PMPnet Group, Cabellos L, Alcántara AM, Ramos I, Barrios P, Crusellas O, Palacio LM, PMPnet Group, Cámara JA, Barriuso J, PMPnet Group, Jiménez JJ, Muñoz-Torres P, Nonell L, Flores R, Médico E, Guaglio M, PMPnet Group, Ros J, Élez E, Tabernero J, Aziz O, Deraco M, Palmer HG, PMPnet Group, PMPnet Group.   +33 more
europepmc   +2 more sources